The role of long noncoding RNAs in ocular angiogenesis and vascular oculopathy

被引：4

作者：

Gandhi, Pranali ^{[1
]}

Wang, Yuzhi ^{[2
]}

Li, Guigang ^{[3
]}

Wang, Shusheng ^{[4
,5
,6
]}

机构：

[1] Tulane Univ, Sch Med, New Orleans, LA 70112 USA

[2] Louisiana State Univ, Sch Med, New Orleans, LA 70112 USA

[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, Wuhan, Hubei, Peoples R China

[4] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA

[5] Tulane Univ, Dept Ophthalmol, New Orleans, LA 70112 USA

[6] Tulane Univ, Tulane Personalized Hlth Inst, New Orleans, LA 70112 USA

来源：

CELL AND BIOSCIENCE | 2024年 / 14卷 / 01期

关键词：

Ocular; Eye disease; Angiogenesis; Long noncoding RNA (lncRNA); NF-KAPPA-B; DIABETIC-RETINOPATHY; CHOROIDAL NEOVASCULARIZATION; MACULAR DEGENERATION; EXPRESSION; RANIBIZUMAB; CELLS; PROLIFERATION; REGULATOR; KNOCKDOWN;

D O I：

10.1186/s13578-024-01217-5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

BackgroundLong noncoding RNAs (lncRNAs) are RNA transcripts over 200 nucleotides in length that do not code for proteins. Initially considered a genomic mystery, an increasing number of lncRNAs have been shown to have vital roles in physiological and pathological conditions by regulating gene expression through diverse mechanisms depending on their subcellular localization. Dysregulated angiogenesis is responsible for various vascular oculopathies, including diabetic retinopathy, retinopathy of prematurity, age-related macular degeneration, and corneal neovascularization. While anti-VEGF treatment is available, it is not curative, and long-term outcomes are suboptimal, and some patients are unresponsive.Results and summaryTo better understand these diseases, researchers have investigated the role of lncRNAs in regulating angiogenesis and models of vascular oculopathies. This review summarizes recent research on lncRNAs in ocular angiogenesis, including the pro-angiogenic lncRNAs ANRIL, HOTAIR, HOTTIP, H19, IPW, MALAT1, MIAT, NEAT1, and TUG1, the anti-angiogenic lncRNAs MEG3 and PKNY, and the human/primate specific lncRNAs lncEGFL7OS, discussing their functions and mechanisms of action in vascular oculopathies.

引用

页数：19